MiR-29b reverses oxaliplatin-resistance in colorectal cancer by targeting SIRT1

Hui Liu(Shanxi Coal Transportation and Sales Group (China)), Xinhua Cheng(Hubei University of Medicine)
Oncotarget
February 1, 2018
Cited by 36


Related Papers